| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 141 |
| 1 | DEXAMETHASONE 1.5 MG | 141 |
| 2 | PREDNISONE | 131 |
| 3 | BORTEZOMIB | 113 |
| 4 | CYCLOPHOSPHAMIDE | 103 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 103 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 103 |
| 7 | METHOTREXATE SODIUM | 76 |
| 8 | METHOTREXATE | 70 |
| 9 | PANTOPRAZOLE | 69 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 6 | 0.0062 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 47 | 0.0056 |
| 2 | BRENTUXIMAB VEDOTIN | 45 | 0.0043 |
| 3 | CEFTAZIDIME | 33 | 0.0043 |
| 4 | NITROUS OXIDE | 8 | 0.0036 |
| 5 | VINBLASTINE SULFATE | 5 | 0.0025 |
| 6 | ARSENIC TRIOXIDE | 5 | 0.0022 |
| 7 | CARMUSTINE | 10 | 0.0021 |
| 8 | EPOETIN ALFA | 25 | 0.0021 |
| 9 | CALCIUM FOLINATE | 10 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 318 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 2 | Alkylating Drug [EPC] | 117 |
| 3 | Platinum-based Drug [EPC] | 116 |
| 4 | Proteasome Inhibitor [EPC] | 116 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 103 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 81 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 80 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 78 |
| 9 | Loop Diuretic [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 31 | 0.0053 |
| 1 | CD30-directed Immunoconjugate [EPC] | 45 | 0.0043 |
| 2 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 2 | 0.0018 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 8 | 0.0010 |
| 6 | Proteasome Inhibitor [EPC] | 116 | 0.0010 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 78 | 0.0008 |
| 8 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 9 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |